Investigating the administration's approval of Spravato, Trump's potential campaign-finance violations, and the promotion of Trump properties.

FOIA request to the U.S. Food & Drug Administration seeking email communications between FDA officials and the White House regarding the anti-depressant nasal spray Spravato (esketamine).